SCHEMBL3736016

SCHEMBL3736016

CC(C)(C)[Si](C)(C)Oc1ccc(C2SCCCS2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PREP P48147 4/20 0.43
CA12 O43570 4/20 0.39
CA1 P00915 4/20 0.39
CA9 Q16790 4/20 0.39
TSHR P16473 1/20 0.36
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 3/20 0.33
NPC1 O15118 1/20 0.33
MAPK1 P28482 1/20 0.33
RAB9A P51151 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
GABRP O00591 2/20 0.32
GABRD O14764 2/20 0.32
GABRA1 P14867 2/20 0.32
GABRB1 P18505 2/20 0.32
GABRG2 P18507 2/20 0.32
GABRB3 P28472 2/20 0.32
GABRA5 P31644 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3093088 0.82 HSP90AA1 (0.38) PREPCA12CA1CA9TSHR
SCHEMBL3726821 0.81 TSHR (0.46) CA12CA1CA9TSHR
SCHEMBL4520328 0.79 NPC1 (0.33) TSHRALDH1A1KDM4ELMNAMAPT
SCHEMBL3090227 0.77 TSHR (0.52) TSHRALDH1A1LMNA
SCHEMBL6763899 0.75 PREP (0.53) PREPCA12CA1CA9ALDH1A1
SCHEMBL1344540 0.74 TSHR (0.50) CA12CA1CA9TSHRALDH1A1
SCHEMBL7632848 0.73 TSHR (0.44) TSHRALDH1A1KDM4ELMNAMAPT
SCHEMBL327430 0.70 GLA (0.51) TSHRALDH1A1KDM4ELMNAMAPT
SCHEMBL9778743 0.70 MAOA (0.53) TSHRALDH1A1KDM4ELMNAMAPT
SCHEMBL8454387 0.70 PREP (0.41) PREPCA12CA1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11117987-B2 Hydroxyaryl functionalized polymers BRIDGESTONE CORPORATION (JP) 2021-09-14 US disclosed
US-11028195-B2 Hydroxyaryl functionalized polymers BRIDGESTONE CORPORATION (JP) 2021-06-08 US disclosed
US-20190322777-A1 Hydroxyaryl Functionalized Polymers BRIDGESTONE CORPORATION (JP) 2019-10-24 US disclosed
US-20190233557-A1 Hydroxyaryl Functionalized Polymers BRIDGESTONE CORPORATION (JP) 2019-08-01 US disclosed
US-10227425-B2 Hydroxyaryl functionalized polymers BRIDGESTONE CORPORATION (JP) 2019-03-12 US disclosed
EP-2937365-B1 METHOD OF MAKING HYDROXYARYL FUNCTIONALIZED POLYMERS BRIDGESTONE CORP (JP) 2016-12-14 EP disclosed
EP-2589611-B1 Method for making hydroxyaryl functionalized polymers BRIDGESTONE CORP (JP) 2016-10-26 EP disclosed
EP-2937365-A1 METHOD OF MAKING HYDROXYARYL FUNCTIONALIZED POLYMERS Bridgestone Corporation (JP) 2015-10-28 EP disclosed
EP-2231719-B1 HYDROXYARYL FUNCTIONALIZED POLYMERS BRIDGESTONE CORP (JP) 2015-07-29 EP disclosed
US-20150141582-A1 Hydroxyaryl Functionalized Polymers BRIDGESTONE CORPORATION (JP) 2015-05-21 US disclosed
US-8871871-B2 Hydroxyaryl functionalized polymers BRIDGESTONE CORPORATION (JP) 2014-10-28 US disclosed
EP-2589611-A1 Hydroxyaryl functionalized polymers Bridgestone Corporation (JP) 2013-05-08 EP disclosed
US-20100286348-A1 HYDROXYARYL FUNCTIONALIZED POLYMERS BRIDGESTONE CORPORATION (JP) 2010-11-11 US disclosed
EP-2231719-A2 HYDROXYARYL FUNCTIONALIZED POLYMERS Bridgestone Corporation (JP) 2010-09-29 EP disclosed
WO-2009086490-A2 HYDROXYARYL FUNCTIONALIZED POLYMERS BRIDGESTONE CORPORATION (JP) 2009-07-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190322777-A1 Hydroxyaryl Functionalized Polymers HAAO, HCAR3, VCL PREP 2872/4885CA12 3887/4885CA1 4613/4885
US-11028195-B2 Hydroxyaryl functionalized polymers HAAO, HCAR3, VCL PREP 3195/4885CA12 3796/4885CA1 4595/4885
US-10227425-B2 Hydroxyaryl functionalized polymers HAAO, HCAR3, VCL PREP 2872/4885CA12 3887/4885CA1 4613/4885
US-20150141582-A1 Hydroxyaryl Functionalized Polymers HAAO, HCAR3, VCL PREP 2872/4885CA12 3887/4885CA1 4613/4885
US-20100286348-A1 HYDROXYARYL FUNCTIONALIZED POLYMERS HAAO, HCAR3, VCL PREP 2872/4885CA12 3887/4885CA1 4613/4885
US-11117987-B2 Hydroxyaryl functionalized polymers HAAO, HCAR3, VCL PREP 2872/4885CA12 3887/4885CA1 4613/4885
US-20190233557-A1 Hydroxyaryl Functionalized Polymers HAAO, HCAR3, VCL PREP 3195/4885CA12 3796/4885CA1 4595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.